Clinical trial
Study SBX-01-101: A Stool Collection Study in Colorectal Cancer (CRC) Patients Treated With Irinotecan-Based Regimens
NCT05821582 is registered in ClinicalTrials.gov with Sanguine Biosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study SBX-01-101: A Stool Collection Study in Colorectal Cancer (CRC) Patients Treated With Irinotecan-Based Regimens
- Lead sponsor
- Sanguine Biosciences
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- March 27, 2023
- Completion date
- October 5, 2023
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer